Chan L S, Takata G S, Shekelle P, Morton S C, Mason W, Marcy S M
Division of Biostatistics and Outcomes Assessment, Los Angeles County-University of Southern California Medical Center, Los Angeles, California 90033, USA.
Pediatrics. 2001 Aug;108(2):248-54. doi: 10.1542/peds.108.2.248.
To report research gaps and priorities of future research identified during an evidence assessment process on the management of acute otitis media (AOM).
A conceptual framework for management of AOM was developed to guide the evidence assessment. An 11-member technical expert panel guided the selection of key questions, prioritization of influencing factors, development of scope, definition of AOM, and search strategy through polling processes and conference calls. Quality of clinical trials was evaluated using established scales. Outcome measures were abstracted from each study.
A total of 3461 titles and abstracts were screened, and 760 full-length articles were reviewed. Of the 760 articles, 80 studies addressed the key questions. In defining AOM, 42 (52.5%) of the 80 studies included the middle-ear effusion component, only 2 (2.5%) included the rapid onset component, and 26 (32.5%) included the signs/symptoms of inflammation component. None of the 80 studies used all 3 components. Of the 74 controlled trials, 39 (53%) were of acceptable quality (Jadad score of 3 or higher). The technical experts did not agree in the ranking of the importance of the 41 influencing factors (Kendall's coefficient of concordance was 0.0022). Another poll also indicated diverse opinions of the experts on the importance of 7 key questions derived from the conceptual framework (Kendall coefficient of concordance is 0.21). Furthermore, our review found that the type and definition of outcome measure varied.
Despite the large body of literature on AOM, its quality is uneven and its findings are not generalizable. Future research should try to answer all key questions and investigate all risk factors in well-designed, scientific studies.
报告在急性中耳炎(AOM)管理的证据评估过程中确定的研究差距和未来研究重点。
制定了AOM管理的概念框架以指导证据评估。一个由11名成员组成的技术专家小组通过投票过程和电话会议指导关键问题的选择、影响因素的优先级排序、范围的制定、AOM的定义以及检索策略。使用既定量表评估临床试验的质量。从每项研究中提取结果指标。
共筛选了3461篇标题和摘要,审查了760篇全文文章。在这760篇文章中,80项研究涉及关键问题。在定义AOM时,80项研究中有42项(52.5%)纳入了中耳积液成分,只有2项(2.5%)纳入了快速起病成分,26项(32.5%)纳入了炎症体征/症状成分。80项研究中没有一项使用了所有这三个成分。在74项对照试验中,39项(53%)质量可接受(Jadad评分3分或更高)。技术专家在41个影响因素的重要性排名上未达成一致(肯德尔和谐系数为0.0022)。另一项投票也表明,专家们对概念框架中7个关键问题的重要性存在不同意见(肯德尔和谐系数为0.21)。此外,我们的综述发现结果指标的类型和定义各不相同。
尽管关于AOM的文献众多,但其质量参差不齐,研究结果也无法推广。未来的研究应尝试在设计良好的科学研究中回答所有关键问题并调查所有风险因素。